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Relationships between ligand binding and the
shapes of the binding sites in families of homolo-
gous enzymes are investigated by comparing
matrices of distances between key binding site
atoms. Multiple linear regression is used to help
identify key distances that inﬂuence ligand bind-
ing afﬁnity. In order to illustrate the utility of this
generic approach, we study protein kinase binding
sites for ATP and the promiscuous competitive
inhibitor, staurosporine. We show that the size of
the gatekeeper residue and the closure between
the ﬁrst glycine of the GXGXXG motif and the
aspartate of the DFG loop act together to promote
tight binding. Our web-based tool, ’mapping analo-
gous hetero-atoms onto residue interactions’
(MAHORI), indicates that the greater the number
of hydrogen bonds made by the kinase around the
methylamine group of staurosporine, the tighter
the binding. The conservation of surrounding
atoms identiﬁed using our novel grid-based
method clearly demonstrates that the most struc-
turally conserved part of the binding site for
staurosporine is the main chain of the hinge
region. The critical role of interactions that are
not dependent on side-chain identities is consis-
tent with the promiscuous nature of this inhibitor.
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Protein kinases catalyze the transfer of a phosphate group, usually
from ATP, to a protein substrate. The human genome comprises
more than 500 protein kinases (1), which are known to mediate
most of signal transduction crucial to metabolism, cell proliferation
and differentiation, membrane transport, and apoptosis. Although
they exhibit a variety of regulatory mechanisms and conformational
states, protein kinases share the same fold and similar ATP-binding
sites (2).
Protein kinases are of considerable interest to the pharmaceutical
industry because dysfunction often results in malignancy (3,4). Kin-
ases are also validated anti-inflammatory drug targets (5). Indeed,
the success of several high-affinity ATP-mimetic drugs has made
the design of selective inhibitors an attractive approach to useful
therapeutics, particularly for oncology (6). Although the structural
conservation of the ATP-binding site can lead to off-target ligand
binding, kinase inhibitor design has become a promising way for-
ward for discovery of useful therapeutic agents (7).
The major challenge for protein kinase inhibitor design is obtaining
selectivity. In order to reduce the chances of undesirable side-
effects, potency is usually optimized against a target kinase while
reducing off-target activities including those involving homologous
proteins. However, the level of selectivity required is dependent on
the therapeutic endpoint. Indeed, in some cases, polypharmacology
is an advantage, although a multi-target selectivity is very difficult
to achieve by design (8).
Insights into protein kinase selectivity and promiscuity are the major
objectives of this article. Although high-affinity targets sometimes
have similar residues at positions important for binding of a given
kinase inhibitor, others with similar residues at these important
positions can be insensitive to such inhibitors, probably because of
conformational differences (9). Therefore, understanding kinase
selectivity cannot be achieved only through the analysis of
sequences but must also consider three-dimensional structures.
Here, in order to understand the relationship between the protein
structure and binding affinities, we study complexes of protein kin-
ases with staurosporine (10), a microbial alkaloid isolated from
Streptomyces staurosporeus. Although staurosporine is a potent
inhibitor of various human protein kinases and has some antifungal
activity, it is too toxic to be used as a drug. However, it has been
widely used in research as a universal kinase inhibitor (11). The
three-dimensional structures of a significant number of protein kin-
ases co-crystallized with staurosporine can be found in the Protein
Data Bank. They show that staurosporine mimics ATP very well, in
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The availability of dissociation constants (Kd) for staurosporine with
119 kinases (12), when used in combination with this structural
information, allows us to relate binding affinities to differences in
the structures of the pockets.
We have studied the relationship between the structures of protein
kinases and their ability to bind promiscuous ligands, which we
define here as compounds that bind several and, in the case of
staurosporine, the majority of kinases on which they are tested. In
order to investigate the factors that determine whether a particular
kinase will bind a particular kinase inhibitor, we have examined the
regions around the pockets of a set of medium-to-high-quality X-ray
crystal structures; and to group kinases based on the similarity in
spatial arrangement of amino acid side chains, we use the Mantel
test, a statistically robust method for calculating correlation coeffi-
cients between distance matrices (13). Our shape-based dendrogram
shows that similarity in shape alone can sometimes determine the
affinity for a set of ligands, regardless of their overall sequence
similarity.
The study of the shapes of the pockets allows us to identify the
factors required for most kinases to bind the promiscuous inhibitor,
staurosporine. We examine the similarities of the shapes of the
pockets by identifying neighboring entities that are conserved in
their positions relative to staurosporine. We show that some are
recruited to staurosporine via an induced fit or conformational
selection mechanism, which contributes to staurosporine promiscu-
ity. We focus on the differences in distance matrices that define
the pockets and show how the side chains affect binding affinities.
Based on a quantitative structure activity relationship (QSAR)
approach, we select a set of distances that have an influence on
binding affinities. These distances indicate that tighter binding is
associated with the closure of the N-lobe and C-lobe and a larger
size of the gatekeeper residue. The numbers of ionic interactions
and hydrogen bonds around the methylamine of staurosporine also
affect the binding affinities.
Methods
Shape correlation by Mantel test
Protein Data Bank identification codes of structures with 'protein
kinase activity', i.e., gene ontology ID GO:0004672 on MSDlite data-
base (14), were filtered through the PISCES server in order to
select representative protein crystal structures based on resolution,
R-factor and completeness (15). The 80 chosen structures with reso-
lutions better than 3.0   and R-factors less than 0.30 were then
superposed onto cyclic AMP-dependent protein kinase (PKA) using
the program BATON based on the method developed in Comparer
(16). PKA, the first protein kinase for which a crystal structure
became available (17), was selected as the template because its
residue nomenclature is widely used in kinase analyses (18). The
obtained structural alignment was used to infer equivalent residues
in the kinase superfamily. Distances between every residue sur-
rounding the pocket were calculated. This was achieved by select-
ing a 'representative' atom, generally located near the end of the
side chain for each amino acid residue. For example, the hydroxyl
oxygen was chosen for serine and the beta-carbon was chosen for
threonine (see Appendix S2). Half-diagonal distance matrices were
constructed and the correlations between the matrices were calcu-
lated by the Mantel test using program ZT (19). Relationships
between distance matrices were defined using the neighbor-joining
algorithm from the program PHYLIP (20) and the dendrogram was
made for comparison using the program TREEVIEW (21). Inter-residue
distances were used which characterize a particular kinase regard-
less of the ligand with which it was crystallized. The equivalent
set of distances was also measured for another set of 35 non-
redundant crystal structures of kinases, which have been assayed
by Fabian et al. (12). These structures contain a variety of inhibitors
bound in the ATP-binding site. This allows the relationship between
the spatial arrangement of residues of different kinases and their
binding affinities (Kd) against 10 ligands to be visualized. We used
the color gradient representation of the tree plotting program ITOL
(22), where the intensities of the colors were proportional to
)log10Kd, in order to allow comparison for millimolar to sub-
nanomolar values of binding constants (Kd).
Position-speciﬁc interactions
The structures of 20 staurosporine–kinase complexes were super-
posed on the indolocarbazole moiety of staurosporine in PDB ID
1stc in order to compare them with the structures of 24 adeno-
sine phosphate–kinase complexes, which were superposed on the
adenine ring from ATP in PDB ID 1atp. The position-specific inter-
actions were considered at two levels: the atom type and the res-
idue type. For the atom-based arrays, atoms in the PDB file were
assigned an atom type according to the simplified approach used
in the AMBER force field, which has been developed specially for
molecular mechanics calculations of proteins and nucleic acids
(23) (Appendix S1). For the residue-based arrays, only 'representa-
tive' atoms and oxygen of water molecules were assigned a resi-
due type (see Appendix S2). We constructed a three-dimensional
grid with 1   dimensions around the rigid part of the superposed
ligands and collected occupancy in the grid boxes based on resi-
due or atom types and x, y, and z coordinates for non-redundant
protein kinase structures. For the atomic level, the grid was
stored in PDB file format and occupancies of boxes were con-
toured using the module color_b of program PYMOL (24) to obtain
a transparent surface with the intensity of the color corresponding
to the frequency with which the grid boxes are populated. For the
residue level, relative positions of neighboring residues for differ-
ent ligands were observed by superposing the majority of the res-
idue clusters surrounding adenine and staurosporine, and then
comparing the positions of these clusters for adenine complexes
and staurosporine complexes. For visualizing the cluster, a bond is
drawn automatically when two atoms come closer than about 2  
so the cluster can be easily found. Colors of frequently occurring
residues are assigned according to the type of amino acid found
in the array.
Distance-based QSAR
We filtered the PDB (25) for X-ray structures of the kinases for
which Fabian et al. (12) report a Kd for staurosporine (Kd,STU), and
selected only those structures that are co-crystallized as either
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in the case of shape analysis, distances from representative atoms
between 15 residues surrounding the pocket were measured to find
the best correlation of distances with Kd,STU. Multiple linear regres-
sion was performed using the program XLSTAT (26) to find the best
equation relating the distances measured between the centre points
near the ends of the side chains (see Appendix S2) and log10Kd,STU.
Amino acid residues used to create these distance descriptors were
extracted by referring to PKA equivalent residues from the ClustalX
(27) multiple sequence alignment of the 113 kinases in Fabian's
data set (12). The relationships of these influential residues were
drawn from the neighbor-joining algorithm in ClustalX (27). The abil-
ities of kinases to bind the inhibitors staurosporine, LY-333531,
SU11248, and ZD-6474 were calculated from )log10Kd, and a den-
drogram was produced with gradient color representation using pro-
gram ITOL (22) in order to reflect these values. The selected
inhibitors are among the most promiscuous ligands in the Fabian
data set, so that the number of the kinases they can bind is suffi-
cient to demonstrate trends in binding affinities.
Because the experimental data depend not only on the method used
but also the experimentalist who reports the values, we choose dis-
sociation constants of staurosporine (Kd,STU) from Fabian et al. (12)
as the sole source of our experimental binding data. Structures in
this training set structure have Kd,STU between 0.5 and 870 nM and
both adenine-containing and staurosporine-bound structures are con-
sidered. We include adenine ring-containing structures in the data
set on the assumption that the rigid part of the pockets that harbor
adenosine or staurosporine share similar conformations and elec-
tronic features. The advantage of assuming that the structure of
adenosine phosphate-bound complex resembles that of the same
enzyme in the staurosporine-bound complex is that there are many
structures in complex with adenosine containing compounds. The
greater number of structures with available Kd,STU allowed us then
to test our equation by predicting Kd,STU for further kinase structures
co-crystallized with adenine ring-containing ligands. We discarded
residue points that differ in position when found in contact with
ATP or staurosporine, so that we could be sure that the differences
in distances were independent of the ligand bound.
Chemical interactions of staurosporine with
various kinases
MAHORI (Mapping analogous hetero-atoms onto residue inter-
actions) is our web-based tool designed to observe interactions
surrounding specific parts of a ligand
a. The website allows for
various types of ligand query e.g., chemical drawing, compound
name, PDB ligand three-letter code and SMILES string. Given the
PDB ligand three-letter hetID of staurosporine (STU), MAHORI
searches the PDB for the staurosporine complexes against the
whole PDB using the PDB-ligand database CREDO (28). This data-
base stores protein–ligand interactions using criteria adapted from
Marcou and Rognan (29). All atoms from the ligand and their
contacting neighbor atoms from the protein have predefined types.
Every contacting atom pair is assigned an interaction type by
considering the type, the geometry and the threshold distance.
The details of residues that interact with the queried atoms are
presented according to the type of interaction, so that molecular
interactions of multiple structures can be compared at the level
of ligand substructure.
Results and Discussion
Ability to bind inhibitors correlates with
spatial arrangement of residues in the pocket
We wished to investigate whether the spatial arrangement of resi-
dues in the ATP-binding pocket has an influence on which inhibitor
the kinase recognizes. In order to avoid comparing extremely vari-
able regions of the pocket, we focused only on protein structures
with staurosporine or adenine ring-containing compounds bound.
We selected a set of points to represent common features of the
pocket and used the Mantel test to distinguish the pockets of dif-
ferent kinases based on the assumption that the matrix of distances
between points surrounding the adenosine pocket can reflect key
features of the pocket shape in multi-dimensions; we call a matrix
of this sort a 'quasi-shape' (Figure 1A and 1B). We used calculated
correlation coefficients among distance matrices of the same size
and order of elements to estimate the similarities in the spatial
arrangements of side chains and hence the relationships between
shape and the ability of parent kinases to bind various inhibitors.
Our preliminary results suggest that Mantel test correlations
between the matrices derived from a small set of inter-atomic dis-
tances can separate the majority of staurosporine complexes from
the adenine-containing complexes. This means that there are obser-
vable differences in spatial arrangement of these atoms when
staurosporine and adenine are bound. Thus, the Mantel Test
appears to work well for classifying different three-dimensional
geometric shapes. However, the same kinase in different crystal
forms can be scattered throughout the resulting shape-based den-
drogram, implying that similarities between conserved atoms are
not able to identify identical kinases in different conformational
states. Therefore, we investigated the use of 'representative' atoms
as the centers for distance measurements in the construction of the
distance matrix, thus allowing the derivation of a quasi-shape from
each PDB file. The choice of these atoms, which depends on their
residue type, is shown in Appendix S2. By gradually increasing the
number of residue points, we were able to cluster the same kinase
in different crystal forms and different complexes into the same
branch of the dendrogram. The most useful shape-based dendro-
gram is constructed from 17 representative points from 17 residues.
These are equivalent to the following residues in PKA: LEU 49, GLY
50, VAL 57, ALA 70, MET 71, LYS 72, VAL 104, MET 120, GLU 121,
TYR 122, VAL 123, GLU 170, ASN 171, THR 183, ASP 184, GLU
127, LEU 173. This dendrogram places the same type of kinase in
different complexes in the same branch regardless of the bound
ligand, and the staurosporine binding structures were clustered into
one-half of the tree (Appendix S3).
We then applied this method to a set of 35 non-redundant protein
kinases and 10 inhibitors from the Fabian et al. data set (12) and
obtained a dendrogram that characterizes the ability to bind 10
ligands, based on the similarity in quasi-shape (Figure 1C). The gen-
eral sequence-based dendrogram is shown for comparison (Fig-
ure 1D). It is evident that kinases with similar pocket quasi-shapes
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Figure 1: Correlation between the shapes of the kinase ATP-binding pockets and their binding affinities to inhibitors. (A, B) The quasi-
shape of the adenine-binding pocket of cAMP-dependent protein kinase (PDB ID:1stc, chain E) in complex with staurosporine (orange stick) is
illustrated by drawing purple lines between the 'representative' atoms of the 17 residues surrounding the pocket. (C) The shape-based dendro-
gram shows the matrix correlation between the shapes of the kinases and their binding affinities to 10 inhibitors. The method employs 17
active-site residues to construct the distance matrices for each kinase and then find the correlations between them. The pocket of STK10, an
STE kinase, shows the greatest similarity in shape to that of LCK, a tyrosine kinase. Their inhibition profiles appear very similar (lower left).
(D) The classic dendrogram based on sequence similarity from structure-based sequence alignment using program BATON. The intensity of the
color is proportional to log10Kd of the inhibitor. It clusters the kinase with similar performance to the shape-based dendrogram. Staurosporine
is the most promiscuous inhibitor in this data set (red).
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their family membership. A nice example is serine⁄threonine kinase
10 (STK10), which is clustered in the sequence-based dendrogram
as an STE kinase, or Homolog of yeast Sterile 7, 11, 20 kinases, as
defined in the protein kinase phylogenetic tree by Manning et al.
(1). When considering STK10 in terms of similarity in spatial
arrangement of residues, it is instead paired with leukocyte-specific
protein tyrosine kinase (LCK) which is a tyrosine kinase. The
sequences are quite different, but the quasi-shape of the pockets
and their abilities to bind seven inhibitors are very similar. Many
kinases with similar sequences, for example CDK2 and CDK5 or
DAPK2 and DAPK3, also have very similar quasi-shapes and inhibi-
tion profiles. This quasi-shape-based dendrogram provides a way of
visualizing relationships among kinases, complementing that of the
classical sequence-based dendrogram. Our dendrogram demon-
strates that the similarity in quasi-shape can sometimes explain the
ability to bind a set of ligands regardless of the overall sequence
identity.
Conserved interaction shows induced-ﬁt
mechanism upon staurosporine binding
We hypothesize that if protein features surrounding a particular
ligand remain conserved both in atom type and position in com-
plexes of different kinases, they may be required for binding the
ligand. We have developed software to extract generalized fea-
tures that are frequently found in protein kinase structures by
constructing four-dimensional arrays to capture different entities
that are conserved in atomic position on structure superposition of
staurosporine complexes. The array collects occupancies of atoms
from superposed structures that satisfy the four criteria, i.e., x,y,z
coordinates and atom type. This approach increases signal to noise
by superposing a significant number of structures (20 structures of
staurosporine complexes).
The staurosporine molecule is quite rigid as it contains very few
rotatable bonds; hence, we may observe interaction partners that
are position-specific by superposing the kinases onto its lactam and
indolocarbazole rings. In a similar manner, interactions around the
adenosine phosphate complexes can be compared by superposing
the non-redundant kinase structures onto the adenine ring (24 struc-
tures of adenine-containing complexes). The conserved atomic envi-
ronment can be found by observing the frequently occurring atoms
at a particular location defined by a 1   grid box (Figure 2A and
2B).
The atom type categorization is based on the assumption that
atoms around the side chains that have the same functional group
CD
B A
Figure 2: Frequently occurring atoms and residues around the ATP- and staurosporine-binding sites. The hinge region is on the left, the
N-terminal lobe at the top and the C-terminal lobe at the bottom of the figure. (A,B) Color is related to the frequency of finding atoms at a
position (CT = sp
3 carbon, C = carbonyl sp
2 carbon, N = sp
2 amide nitrogen, O = sp
2 oxygen). Both staurosporine (white stick) and the adenine
ring (yellow stick) are recognized by the main chain atoms in the hinge region on the left. The atomic environment of adenine (A) shows more
variability than that of staurosporine (B) as shown by the maximum occupancy of frequently occurring atoms (58%); this is smaller than that
of staurosporine (75%). (C) The first glycine of the GXGXXG motif in purple moves within a rhombohedron-shaped volume when located near
the adenine ring. This glycine retains its position in the same grid in 75% of staurosporine structures (15 from 20 structures) indicating
induced fit of the glycine-rich loop when located near staurosporine (D).
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of Asp and Glu have sp
2-oxygen atom types (Appendix S1). By this
approach, we can capture similar interactions in the pocket made
by similar parts of ligands. The resulting atomic level arrays suggest
that for both adenine and staurosporine ligand complexes (Figure 2A
and 2B), the main chain atoms of the kinase make the most con-
served interactions in terms of type and position, which explains
why staurosporine, mimicking ATP, can bind to most of the kinases.
The conserved neighboring atoms of ATP are more variable in
position than those of staurosporine (38–58% conservation in
Figure 2A versus 50–75% in Figure 2B). This supports the idea that
the two ligands require a different degree of flexibility within the
active site of the kinase. The greater number of rotatable bonds in
the adenosine phosphate results in lower degree of conservation of
neighboring atoms in these complexes than in staurosporine
complexes. The ribose moiety of the adenosine complex can adopt
several conformations, so the frequently occurring atoms fall in
several grid boxes. The main chains of protein kinases in the hinge
regions interact with the amine group of the adenine rings and are
the most conserved parts of the adenine complexes. In a similar way,
the main chains of the hinge regions, which interact with the lactam
oxygen, and the a-carbons of the first glycines of the GXGXXG motifs,
which interact with the tetrahydropyran, are the most conserved
parts for staurosporine complexes. Furthermore, for 15 out of 20
staurosporine-bound structures, the main chain alpha carbons from
the first glycine of the G-rich loop fall in the same 1   grid box
(Figure 2D). When superposed on the adenine ring, these atoms are
distributed within a rhombohedron-shaped volume (see Figure 2C). It
is perhaps surprising that this glycine can become fixed in position
upon staurosporine binding because the glycine-rich loop is generally
believed to be highly flexible (30,31). The relatively well-conserved
position of this glycine, but not for adenine complexes, suggests that
the staurosporine causes an induced fit or conformational selection
in the kinases upon binding. However, further evidence from apo
structures is required to confirm this observation.
The residue arrays serve to complement the pictorial representa-
tions of the atomic environment. For most of the residues, we
chose the penultimate atoms of the side chains to represent the
identities and the positions of the residues (Appendix S2). In this
way, residues with a similar functional group at the end of the side
chain in different kinases can be captured as points at similar loca-
tions in the superposed structures. For instance, Cb of valine and
Cc of leucine at the active sites occupy the same or close-by grid
boxes in the superposed structures. We observe that some clusters
of amino acids preserve their functional groups in most of the
staurosporine and the adenine complexes; examples are the side
chains of glutamate and aspartate of the salt-bridges which flank
the pocket on both sides, the residues that are equivalent to Ala70
in PKA which acts as the ceiling of the cleft, and again Gly50 which
interacts with the ether oxygen of the ribose (Figure 2C and 2D).
Several clusters of amino acids are seen to have moved, leading to
contraction and expansion of the residues in the pocket to accom-
modate staurosporine.
The ends of some similar hydrophobic side chains, including Cys
and Met, or Ala, Val and Leu, which surround the planar indolocar-
bazole ring, have equivalent positions, implying that these amino
acids perform the same function in that part of the active site. On
the contrary, the amino acids that make contact around the methyl
amino and methoxy groups of staurosporine demonstrate that
remarkably different functional groups can occupy the same position
and carry out the same structural role.
Distance descriptors and interaction types
correlate with the magnitudes of binding
afﬁnities
Staurosporine has very few strongly electrostatic features. Its major
interactions with protein kinases are largely steric with non-polar
groups. Thus, we hypothesized that the tightness of inhibitor bind-
ing might be determined by the compactness of residues in the
pocket. In order to test this idea and to predict binding affinities
from the structures, we assumed that good binding requires certain
geometric restraints and investigated which distance descriptors
correlate well with the dissociation constants. Thus, if distances
are shorter for most of the structures with low binding constants,
we investigate whether contraction along that direction is required
for tight binding. This approach resembles QSAR, but all the input
parameters are measured from the structure in terms of distances
that constitute the quasi-shape of the ATP-binding pocket. Although
QSAR methodologies have been widely used to try to understand
binding affinities through various parameters related to lipophilicity,
charge and hydrogen bonding character (32), distances between cer-
tain atoms in the protein have not been used.
In order to select distances from the quasi-shape defined by 15
points in contact with staurosporine (Figure 1A and 1B; Appen-
dix S4), we carried out multiple linear regression with the equations
shown in Table 1. We tested the predictive power of these equa-
tions by leaving out randomly selected test sets. While the purpose
of using multiple linear regression in this context was simply to
select the set of distances that correlate well with the binding
affinities, the resulting equations suggest that predictive power
might be demonstrated if a larger data set were available. All
resulting equations appear to contain the same best sets of dis-
tances producing R
2 values for the random test sets of about 0.7
for both equations (Appendix S5).
The distance descriptors which correlate well with binding affini-
ties, either having positive or negative influence on Kd,STU, are
called the 'influential distances'. Although correlation does not
imply causation, examination of the crystal structures allows us to
interpret these results in terms of structure. Figure 3A illustrates
these influential distances in the structure of PKA, PDB ID 1stc.
They can be used to describe how positions of representative side-
Table 1: Equations correlating the influential distances with
log10Kd,STU
Random Test
R
2
training
R
2 test
set Equation
None 0.6 – log10Kd,STU = 3.4 + 0.1D50_184)0.4D120_123
5 Structures 0.6 0.7 log10Kd,STU = 3.4 + 0.1D50_184)0.4D120_123
10 Structures 0.7 0.7 log10Kd,STU = 3.6 + 0.1D50_184)0.4D120_123
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major changes in neighboring atomic positions around the stauro-
sporine (Figure 3C).
Of the equations shown in Table 1, the distance between residues
50 and 184, described in equation as D50_184, is directly propor-
tional to the value of log10Kd,STU, and the distance between residue
120 and 123, D120_123, is inversely proportional to log10Kd,STU.A
possible interpretation of the equation is that in kinases that are
tightly bound to staurosporine, i.e., have a small log10Kd,STU, there
is a preference for a smaller D50_184 and a larger D120_123. In PKA,
the distance between residues 50 and 184 is measured between
Ca of Gly50 of the GXGXXG motif in N-terminal lobe to Cc of
Asp184 of the DFG loop in C-terminal lobe. Staurosporine is located
between the two lobes, and the closer approach of these two
motifs in a direction perpendicular to the plane of staurosporine
reflects the better binding affinities presumably because of the
resultant tighter binding. In contrast, the distance between residue
120 (gatekeeper) and 123 (gatekeeper + 3) implies the expansion of
the pocket along this direction. The equation suggests that
these two residues should move further apart to accommodate
staurosporine. The gatekeeper residue points toward the plane of
staurosporine, while the gatekeeper + 3 residue is located under
the indolocarbazole ring. The size of the gatekeeper and the gate-
keeper + 3 residues appear to have a key role in locking the lactam
in the correct orientation while making optimal steric interactions
with the indolocarbazole of staurosporine. The larger size of the
gatekeeper residue likely results in the larger distance and corre-
lates with good binding because the larger volumes of the side
chains in the plane of the lactam ring promote favorable hydropho-
bic interactions in the pocket.
We speculated that the interactions involving the methyl amino
(N4¢) and the methoxy group (O3¢) of staurosporine should constrain
AB
D
C
Figure 3: The interpretation of multiple linear regression equations. (A) Interpretation of the multiple linear regression analysis shows that
smaller values of Kd,STU result from the larger size of side chains of the gatekeeper and gatekeeper + 3 residues, i.e., PKA equivalent residue:
Met120 and Val123 (orange bar). The equation suggests that the closer approach between Gly50 of the N-terminal lobe and Asp184 of the C-ter-
minal lobe (purple bar) correlate with tighter binding to staurosporine. (B) A dendrogram displaying relationships between 113 kinases based
on neighbor-joining of the 13 residues which are in contact with staurosporine and show correlation (<)0.4 and >0.4) with Kd,STU. The aim is
to investigate whether the similarities between these influential residues, equivalent to PKA residues 49, 50, 57, 70, 71, 72, 120, 121, 122,
123, 170, 171, and 184, give rise to similar binding constants. The resulting dendrogram can cluster staurosporine tight binders into two
major groups with better binding affinity to staurosporine (dark red). This group of kinases tends to have large gatekeeper residues, e.g., Phe
(F), Met (M). Smaller gatekeeper residues, e.g., Thr or Leu, tend to be associated with weaker binding affinities to staurosporine. A majority
of kinases which are inhibited by ZD-6474 (blue) has threonine (T) or valine (V) as a gatekeeper residue. Binding affinities to LY-333531
(green) and SU11248 (yellow) are shown for comparison. (C) Staurosporine structural components. (D) Chemical structure of staurosporine
based on annotation from Zhao et al. (33).
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value (Figure 3D). Indeed, the hydrogen bonds or ionic interactions
that the staurosporine can make along this direction are associated
with the major differences in the binding affinities. We find that
the number of hydrogen bonds made by residues around N4¢ of
staurosporine corresponds well with the trend in binding affinities
(Table 2). Kinase structures that have two residues making hydrogen
bonds or ionic interactions to N4¢ of staurosporine, i.e., CDK2, PKA,
PIM1, and LCK, have binding affinities below 51 nM. Most struc-
tures that have only one residue contributing hydrogen bonds or
ionic interaction to N4¢ have binding affinities between 51 and
440 nM, i.e., CSK, EGFR, FYN, M3K5. The kinase STK16 which does
not make any interaction with N4¢ has a binding affinity of 200 nM.
Therefore, in order to modify staurosporine to achieve better affinity
for kinases, the strategy might be to identify a residue close to the
methyl amino (N4¢) and to modify the staurosporine to make another
hydrogen bond. Making point mutations of active site residues in
order to achieve a better binding affinity to staurosporine might
also be achieved by selecting the residue type that can make an
optimal hydrogen bond to N4¢ and O3¢ of staurosporine.
Conclusion
Simple comparison of distance matrices, generated from representa-
tive atoms toward the ends of side-chains, can be used to describe
the geometry of a ligand binding site and this can be related to
inhibitor binding. By considering the similarities and differences in
the active sites, our computational approach can rediscover several
kinase binding determinants that have been previously identified
from manual and experimental analyses. We show by grouping
structures with similar inhibition profiles that the shape of the
pocket can contribute to inhibitor selectivity. The most significant
part of the protein kinase structures that remains fixed in type and
position for both staurosporine and adenosine structures is the
main chain at the beginning of the hinge region. This implies that
the reason that staurosporine binds to most kinases is that the lac-
tam from staurosporine and adenine from ATP recognize a similar
set of atoms. Our observation gives a more precise picture of the
induced fit of the conserved glycine-rich loop upon binding to
staurosporine. In addition, our statistical analysis shows that a lar-
ger size of the gatekeeper residues normally results in tight binding
to staurosporine. We have also learned that the hydrogen bond and
ionic interaction made with methylamine is important to the tight-
ness of the binding with staurosporine.
These results indicate that by understanding differences in the
active sites, we can identify residues that affect the ability to bind
the inhibitor and also suggest the part of the inhibitor that might
be modified to achieve better binding affinities. This approach
offers a new perspective on computational descriptions of specific-
ity determinants when a series of different proteins with the same
ligand becomes available.
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